Class information for:
Level 1: PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10210 1018 32.0 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
276 18466 BREAST CANCER//ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PEGFILGRASTIM Author keyword 203 78% 13% 133
2 FEBRILE NEUTROPENIA Author keyword 41 23% 15% 154
3 FILGRASTIM Author keyword 39 33% 10% 99
4 CHEMOTHERAPY INDUCED NEUTROPENIA Author keyword 24 67% 2% 22
5 GRANULOCYTE COLONY STIMULATING FACTORS Author keyword 13 58% 1% 15
6 RELATIVE DOSE INTENSITY Author keyword 8 44% 1% 14
7 LIPEGFILGRASTIM Author keyword 8 100% 0% 5
8 GRANULOCYTE COLONY STIMULATING FACTORS G CSF Author keyword 6 80% 0% 4
9 PEGYLATED G CSF Author keyword 6 71% 0% 5
10 XM02 Author keyword 6 100% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PEGFILGRASTIM 203 78% 13% 133 Search PEGFILGRASTIM Search PEGFILGRASTIM
2 FEBRILE NEUTROPENIA 41 23% 15% 154 Search FEBRILE+NEUTROPENIA Search FEBRILE+NEUTROPENIA
3 FILGRASTIM 39 33% 10% 99 Search FILGRASTIM Search FILGRASTIM
4 CHEMOTHERAPY INDUCED NEUTROPENIA 24 67% 2% 22 Search CHEMOTHERAPY+INDUCED+NEUTROPENIA Search CHEMOTHERAPY+INDUCED+NEUTROPENIA
5 GRANULOCYTE COLONY STIMULATING FACTORS 13 58% 1% 15 Search GRANULOCYTE+COLONY+STIMULATING+FACTORS Search GRANULOCYTE+COLONY+STIMULATING+FACTORS
6 RELATIVE DOSE INTENSITY 8 44% 1% 14 Search RELATIVE+DOSE+INTENSITY Search RELATIVE+DOSE+INTENSITY
7 LIPEGFILGRASTIM 8 100% 0% 5 Search LIPEGFILGRASTIM Search LIPEGFILGRASTIM
8 GRANULOCYTE COLONY STIMULATING FACTORS G CSF 6 80% 0% 4 Search GRANULOCYTE+COLONY+STIMULATING+FACTORS+G+CSF Search GRANULOCYTE+COLONY+STIMULATING+FACTORS+G+CSF
9 PEGYLATED G CSF 6 71% 0% 5 Search PEGYLATED+G+CSF Search PEGYLATED+G+CSF
10 XM02 6 100% 0% 4 Search XM02 Search XM02

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SINGLE ADMINISTRATION PEGFILGRASTIM 290 85% 15% 153
2 DAILY FILGRASTIM 227 81% 13% 135
3 FEBRILE NEUTROPENIA 65 29% 19% 190
4 CHEMOTHERAPY INDUCED NEUTROPENIA 45 48% 7% 69
5 INDUCED FEBRILE NEUTROPENIA 43 57% 5% 52
6 DOSE INTENSITY 39 26% 13% 130
7 PEGFILGRASTIM 31 52% 4% 43
8 RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY 27 78% 2% 18
9 RELATIVE DOSE INTENSITY 26 68% 2% 23
10 EARLY LYMPHOPENIA 22 81% 1% 13

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review 2015 2 43 91%
Management of Chemotherapy-Induced Neutropenia: Measuring Quality, Cost, and Value 2015 3 26 58%
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management 2004 203 37 68%
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review 2014 5 44 68%
Clinical experience with ZarzioA (R) in Europe: what have we learned? 2013 12 26 77%
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis 2011 33 35 71%
Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors 2013 10 28 68%
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis 2012 11 16 88%
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials 2013 18 21 38%
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline 2006 668 105 16%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ECPM EXECUT OFF 4 75% 0.3% 3
2 HLTH SERV OUTCOMES PROGRAM 3 100% 0.3% 3
3 AUSTRIAN BREAST COLORECTAL CANC STUDY GRP 3 60% 0.3% 3
4 GBG FOR GMBH 3 60% 0.3% 3
5 SWEDISH BREAST CANC GRP 3 60% 0.3% 3
6 HUTCHINSON CANC OUTCOMES 3 35% 0.6% 6
7 EUROPEAN PHARMACEUT MED 1 19% 0.7% 7
8 HAEMATONCOL 1 38% 0.3% 3
9 BIOSIMILARS CLIN DEV 1 100% 0.2% 2
10 BREAST EUROPEAN ADJUVANT STUDIES TEAM 1 50% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000148034 HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER
2 0.0000137833 G CSF//GM CSF//GRANULOCYTE COLONY STIMULATING FACTOR
3 0.0000119865 FEBRILE NEUTROPENIA//NEUTROPENIA//NEUTROPENIC FEVER
4 0.0000093103 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL
5 0.0000076054 BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES
6 0.0000071668 FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA
7 0.0000070394 DOSE BANDING//CHEMOTHERAPY DOSING//GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM
8 0.0000065369 PLERIXAFOR//LARGE VOLUME LEUKAPHERESIS//STEM CELL MOBILIZATION
9 0.0000060096 INFLAMMATORY BREAST CANCER//NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER
10 0.0000059832 CYCLIC THROMBOCYTOPENIA//CYCLICAL NEUTROPENIA//ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA